restricting the use of Tasmar (tolcapone) due to reports of serious liver toxicity

The FDA and HPB are restricting the use of Tasmar (tolcapone) due to reports of serious liver toxicity......

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login